|
1
|
Magee JA, Piskounova E and Morrison SJ:
Cancer stem cells: Impact, heterogeneity, and uncertainty. Cancer
Cell. 21:283–296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Visvader JE and Lindeman GJ: Cancer stem
cells: Current status and evolving complexities. Cell Stem Cell.
10:717–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Prince ME, Sivanandan R, Kaczorowski A,
Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles
LE: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zöller M: CD44: Can a cancer-initiating
cell profit from an abundantly expressed molecule? Nat Rev Cancer.
11:254–267. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chikamatsu K, Ishii H, Takahashi G,
Okamoto A, Moriyama M, Sakakura K and Masuyama K: Resistance to
apoptosis-inducing stimuli in CD44+ head and neck
squamous cell carcinoma cells. Head Neck. 34:336–343. 2012.
View Article : Google Scholar
|
|
7
|
Harper LJ, Costea DE, Gammon L, Fazil B,
Biddle A and Mackenzie IC: Normal and malignant epithelial cells
with stem-like properties have an extended G2 cell cycle phase that
is associated with apoptotic resistance. BMC Cancer. 10:1662010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Joshua B, Kaplan MJ, Doweck I, Pai R,
Weissman IL, Prince ME and Ailles LE: Frequency of cells expressing
CD44, a head and neck cancer stem cell marker: Correlation with
tumor aggressiveness. Head Neck. 34:42–49. 2012. View Article : Google Scholar
|
|
9
|
Orian-Rousseau V: CD44, a therapeutic
target for metastasising tumours. Eur J Cancer. 46:1271–1277. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li-Weber M: New therapeutic aspects of
flavones: The anti-cancer properties of Scutellaria and its main
active constituents Wogonin, Baicalein and Baicalin. Cancer Treat
Rev. 35:57–68. 2009. View Article : Google Scholar
|
|
11
|
Zha LH, He LS, Lian FM, Zhen Z, Ji HY, Xu
LP and Tong XL: Clinical strategy for optimal traditional Chinese
medicine (TCM) herbal dose selection in disease therapeutics:
Expert consensus on classic TCM herbal formula dose conversion. Am
J Chin Med. 43:1515–1524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peng H, He Y, Zheng G, Zhang W, Yao Z and
Xie W: Meta-analysis of traditional herbal medicine in the
treatment of nonalcoholic fatty liver disease. Cell Mol Biol
(Noisy-le-grand). 62:88–95. 2016.
|
|
13
|
Sumino M, Saito Y, Ikegami F, Hirasaki Y
and Namiki T: Extraction efficiency of shosaikoto (xiaochaihu tang)
and investigation of the major constituents in the residual crude
drugs. Evid Based Complement Alternat Med. 2012:8905242012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He JX, Ohno K, Tang J, Hattori M, Tani T
and Akao T: Da-Chaihu-Tang alters the pharmacokinetics of
nifedipine in rats and a treatment regimen to avoid this. J Pharm
Pharmacol. 66:1623–1630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kato S, Hayashi S, Kitahara Y, Nagasawa K,
Aono H, Shibata J, Utsumi D, Amagase K and Kadowaki M: Saireito
(TJ-114), a Japanese traditional herbal medicine, reduces
5-fluorouracil-induced intestinal mucositis in mice by inhibiting
cytokine-mediated apoptosis in intestinal crypt cells. PLoS One.
10:e01162132015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Su SB, Xie MJ, Sawabu N and Motoo Y:
Suppressive effect of herbal medicine saikokeishito on acinar cell
apoptosis in rat spontaneous chronic pancreatitis. Pancreatology.
7:28–36. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Iijima H, Daikonya A, Takamatsu S, Kanno
A, Magariyama K, Yoshikawa K, Takamiya T, Ueda Y, Yakubo S,
Matsumoto T, et al: Effects of the herbal medicine composition
'Saiko-ka-ryukotsu-borei-To' on the function of endothelial
progenitor cells in hypertensive rats. Phytomedicine. 20:196–201.
2013. View Article : Google Scholar
|
|
18
|
Nakayama T, Suzuki S, Kudo H, Sassa S,
Nomura M and Sakamoto S: Effects of three Chinese herbal medicines
on plasma and liver lipids in mice fed a high-fat diet. J
Ethnopharmacol. 109:236–240. 2007. View Article : Google Scholar
|
|
19
|
Ben-Arye E, Mahajna J, Aly R, Ali-Shtayeh
MS, Bentur Y, Lev E, Deng G and Samuels N: Exploring an herbal
'wonder cure' for cancer: A multidisciplinary approach. J Cancer
Res Clin Oncol. 142:1499–1508. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chung VC, Wu X, Lu P, Hui EP, Zhang Y,
Zhang AL, Lau AY, Zhao J, Fan M, Ziea ET, et al: Chinese herbal
medicine for symptom management in cancer palliative care:
Systematic review and meta-analysis. Medicine (Baltimore).
95:e27932016. View Article : Google Scholar
|
|
21
|
Ohtake N, Nakai Y, Yamamoto M, Sakakibara
I, Takeda S, Amagaya S and Aburada M: Separation and isolation
methods for analysis of the active principles of Sho-saiko-to (SST)
oriental medicine. J Chromatogr B Analyt Technol Biomed Life Sci.
812:135–148. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yoshie F, Iizuka A, Komatsu Y, Matsumoto
A, Itakura H and Kondo K: Effects of Dai-saiko-to (Da-Chai-Hu-Tang)
on plasma lipids and atherosclerotic lesions in female heterozygous
heritable Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits.
Pharmacol Res. 50:223–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kishida Y, Miki H, Nishii T, Inoue T,
Nishida S, Yoshikawa H and Sugano N: Therapeutic effects of
Saireito (TJ-114), a traditional Japanese herbal medicine, on
postoperative edema and inflammation after total hip arthroplasty.
Phytomedicine. 14:581–586. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ohta Y, Kongo-Nishimura M, Hayashi T,
Kitagawa A, Matsura T and Yamada K: Saikokeishito extract exerts a
therapeutic effect on α-naphthylisothiocyanate-induced liver injury
in rats through atenuation of enhanced neutrophil infiltration and
oxidative stress in the liver tissue. J Clin Biochem Nutr.
40:31–41. 2007. View Article : Google Scholar
|
|
25
|
Yoshie F, Iizuka A, Kubo M, Komatsu Y,
Matsumoto A, Itakura H, Takeda H, Matsumiya T and Kondo K:
Protective effects of Saiko-ka-ryukotsu-borei-to
(Chai-Hu-Jia-Long-Gu-Mu-Li-Tang) against atherosclerosis in
Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits. Pharmacol
Res. 43:481–488. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ohkoshi E, Nagashima T, Sato H, Fujii Y,
Nozawa K and Nagai M: Simple preparation of baicalin from
Scutellariae Radix. J Chromatogr A. 1216:2192–2194. 2009.
View Article : Google Scholar
|
|
27
|
Umemura N, Zhu J, Mburu YK, Forero A,
Hsieh PN, Muthuswamy R, Kalinski P, Ferris RL and Sarkar SN:
Defective NF-κB signaling in metastatic head and neck cancer cells
leads to enhanced apoptosis by double-stranded RNA. Cancer Res.
72:45–55. 2012. View Article : Google Scholar
|
|
28
|
Trinh HT, Joh EH, Kwak HY, Baek NI and Kim
DH: Anti-pruritic effect of baicalin and its metabolites, baicalein
and oroxylin A, in mice. Acta Pharmacol Sin. 31:718–724. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takahashi H, Chen MC, Pham H, Angst E,
King JC, Park J, Brovman EY, Ishiguro H, Harris DM, Reber HA, et
al: Baicalein, a component of Scutellaria baicalensis, induces
apoptosis by Mcl-1 down-regulation in human pancreatic cancer
cells. Biochim Biophys Acta. 1813:1465–1474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Donald G, Hertzer K and Eibl G: Baicalein
- an intriguing therapeutic phytochemical in pancreatic cancer.
Curr Drug Targets. 13:1772–1776. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Naveenkumar C, Asokkumar S,
Raghunandhakumar S, Jagan S, Anandakumar P, Augustine TA, Kamaraj S
and Devaki T: Potent antitumor and antineoplastic efficacy of
baicalein on benzo(a) pyrene-induced experimental pulmonary
tumorigenesis. Fundam Clin Pharmacol. 26:259–270. 2012. View Article : Google Scholar
|
|
32
|
Weiss JM, Bagley S, Hwang WT, Bauml J,
Olson JG, Cohen RB, Hayes DN and Langer C: Capecitabine and
lapatinib for the first-line treatment of metastatic/recurrent head
and neck squamous cell carcinoma. Cancer. 122:2350–2355. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kurokawa M, Ise N, Omi K, Goishi K and
Higashiyama S: Cisplatin influences acquisition of resistance to
molecular-targeted agents through epithelial-mesenchymal
transition-like changes. Cancer Sci. 104:904–911. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chappell J and Dalton S: Altered cell
cycle regulation helps stem-like carcinoma cells resist apoptosis.
BMC Biol. 8:632010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schreiber V, Dantzer F, Ame JC and de
Murcia G: Poly(ADP-ribose): Novel functions for an old molecule.
Nat Rev Mol Cell Biol. 7:517–528. 2006. View Article : Google Scholar : PubMed/NCBI
|
